Cellular endocytosis and gene delivery

Molecular Medicine

Volumn 16, Issue 5-6, 2010, Pages 222-229

  Ziello, Jennifer E ^a,b   Huang, Yan ^a   Jovin, Ion S ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENIC PROTEIN; CAVEOLIN; CLATHRIN; COMPLEMENTARY DNA; DOXORUBICIN; FIBROBLAST GROWTH FACTOR; LIPOSOME; NAKED DNA; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; SINGLE STRANDED DNA; SMALL INTERFERING RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN;

ARTICLE; CELL MIGRATION; CLINICAL TRIAL; CYSTIC FIBROSIS; ENDOCYTOSIS; EX VIVO STUDY; GLIOBLASTOMA; HEART DISEASE; HUMAN; IMMUNE DEFICIENCY; IN VIVO STUDY; ISCHEMIA; LIPID RAFT; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER CIRRHOSIS; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; DNA; ENDOCYTOSIS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MICE;

EID: 77951956539     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00101     Document Type: Article

References (79)

1. Clague MJ. (1998) Molecular aspects of the endocytic pathway. Biochem. J. 336(Pt 2):271-82.
2. Marsh M, McMahon HT. (1999) The structural era of endocytosis. Science. 285:215-20.
3. Anderson RG. (1998) The caveolae membrane system. Annu. Rev. Biochem. 67:199-225.
4. Ohno H, et al. (1995) Interaction of tyrosine- based sorting signals with clathrin-associated proteins. Science. 269:1872-5.
5. Heilker R, Manning-Krieg U, Zuber JF, Spiess M. (1996) In vitro binding of clathrin adaptors to sorting signals correlates with endocytosis and basolateral sorting. EMBO J. 15:2893-9.
6. Ferguson SS, et al. (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science. 271:363-6.
7. Damke H. (1996) Dynamin and receptor-mediated endocytosis. FEBS Lett. 389:48-51.
8. Grabs D, et al. (1997) The SH3 domain of amphiphysin binds the proline-rich domain of dynamin at a single site that defines a new SH3 binding consensus sequence. J. Biol. Chem. 272:13419-25.
9. Barylko B, et al. (1998) Synergistic activation of dynamin GTPase by Grb2 and phosphoinositides. J. Biol. Chem. 273:3791-7.
10. Wang Z, Moran MF. (1996) Requirement for the adapter protein GRB2 in EGF receptor endocyto-sis. Science. 272:1935-9.
11. Yarar D, Waterman-Storer CM, Schmid SL. (2005) A dynamic actin cytoskeleton functions at multi-ple stages of clathrin-mediated endocytosis. Mol. Biol. Cell. 16:964-75.
12. Connolly CN, Futter CE, Gibson A, Hopkins CR, Cutler DF. (1994) Transport into and out of the Golgi complex studied by transfecting cells with cDNAs encoding horseradish peroxidase. J. Cell Biol. 127:641-52.
13. Parton RG, Way M, Zorzi N, Stang E. (1997) Caveolin-3 associates with developing T-tubules during muscle differentiation. J. Cell Biol. 136:137-54.
14. Rothberg KG, et al. (1992) Caveolin, a protein component of caveolae membrane coats. Cell. 68:673-82.
15. Monier S, et al. (1995) VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell. 6:911-27.
16. Murata M, et al. (1995) VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. U. S. A. 92:10339-43.
17. Glenney JR Jr. (1989) Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J. Biol. Chem. 264:20163-6.
18. Fra AM, Williamson E, Simons K, Parton RG. (1995) De novo formation of caveolae in lympho-cytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. U. S. A. 92:8655-9.
19. Kang YS, Ko YG, Seo JS. (2000) Caveolin internal-ization by heat shock or hyperosmotic shock. Exp. Cell Res. 255:221-8.
20. Le PU, Guay G, Altschuler Y, Nabi IR. (2002) Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. J. Biol. Chem. 277:3371-9.
21. Lamaze C, et al. (2001) Interleukin 2 receptors and detergent-resistant membrane domains de-fine a clathrin-independent endocytic pathway. Mol. Cell. 7:661-71.
22. Murata T, et al. (2007) Genetic evidence sup-porting caveolae microdomain regulation of calcium entry in endothelial cells. J. Biol. Chem. 282:16631-43.
23. Le Lay S, et al. (2006) Cholesterol-induced caveolin targeting to lipid droplets in adipocytes: a role for caveolar endocytosis. Traffic. 7:549-61.
24. Oh P, McIntosh DP, Schnitzer JE. (1998) Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol. 141:101-14.
25. Sweitzer SM, Hinshaw JE. (1998) Dynamin undergoes a GTP-dependent conformational change causing vesiculation. Cell. 93:1021-9.
26. Gruenberg J. (2001) The endocytic pathway: a mosaic of domains. Nat. Rev. Mol. Cell. Biol. 2:721-30.
27. van Meer G, Stelzer EH, Wijnaendts-van-Resandt RW, Simons K. (1987) Sorting of sphingolipids in epithelial (Madin-Darby canine kidney) cells. J. Cell Biol. 105:1623-35.
28. Brown DA, Rose JK. (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 68:533-44.
29. Glebov OO, Bright NA, Nichols BJ. (2006) Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell Biol. 8:46-54.
30. Shevchuk AI, et al. (2008) Endocytic pathways: combined scanning ion conductance and surface confocal microscopy study. Pflugers Arch. 456:227-35.
31. Frick M, et al. (2007) Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding. Curr. Biol. 17:1151-6.
32. Cheng ZJ, et al. (2006) Distinct mechanisms of clathrin-independent endocytosis have unique sphingolipid requirements. Mol. Biol. Cell. 17:3197-210.
33. Johannes L, Lamaze C. (2002) Clathrin-dependent or not: is it still the question? Traffic. 3:443-451.
34. Sharma P, Sabharanjak S, Mayor S. (2002) Endocytosis of lipid rafts: an identity crisis. Semin. Cell Dev. Biol. 13:205-14.
35. Swanson JA, Watts C. (1995) Macropinocytosis. Trends Cell Biol. 5:424-8.
36. Aniento F, Emans N, Griffiths G, Gruenberg J. (1993) Cytoplasmic dynein-dependent vesicular transport from early to late endosomes. J. Cell Biol. 123:1373-87.
37. Wei ML, Bonzelius F, Scully RM, Kelly RB, Her-man GA. (1998) GLUT4 and transferrin receptor are differentially sorted along the endocytic path-way in CHO cells. J. Cell Biol. 140:565-75.
38. Yamashiro DJ, Tycko B, Fluss SR, Maxfield FR. (1984) Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway. Cell. 37:789-800.
39. Tjelle TE, Brech A, Juvet LK, Griffiths G, Berg T. (1996) Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation. J. Cell Sci. 109(Pt 12):2905-14.
40. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S. (1988) The mannose 6-phosphate re-ceptor and the biogenesis of lysosomes. Cell. 52:329-41.
41. Mullock BM, Bright NA, Fearon CW, Gray SR, Luzio JP. (1998) Fusion of lysosomes with late endosomes produces a hybrid organelle of intermediate density and is NSF dependent. J. Cell Biol. 140:591-601.
42. Bucci C, et al. (1992) The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell. 70:715-28.
43. Ren M, et al. (1998) Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes. Proc. Natl. Acad. Sci. U. S. A. 95:6187-92.
44. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. (2004) Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377:159-69.
45. Tomko RP, Xu R, Philipson L. (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B cox-sackieviruses. Proc. Natl. Acad. Sci. U. S. A. 94:3352-6.
46. Bergelson JM, et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1320-3.
47. Medina-Kauwe LK. (2003) Endocytosis of adenovirus and adenovirus capsid proteins. Adv. Drug Deliv. Rev. 55:1485-96.
48. Lai CM, Lai YK, Rakoczy PE. (2002) Adenovirus and adeno-associated virus vectors. DNA Cell Biol. 21:895-913.
49. Spencer BJ, Verma IM. (2007) Targeted delivery of proteins across the blood-brain barrier. Proc. Natl. Acad. Sci. U. S. A. 104:7594-9.
50. Wohlfahrt ME, Beard BC, Lieber A, Kiem HP. (2007) A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models. Cancer Res. 67:8783-90.
51. Mohler ER 3rd, et al. (2003) Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial. Vasc. Med. 8:9-13.
52. Rajagopalan S, et al. (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 108:1933-8.
53. Flotte TR, et al. (2003) Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum. Gene Ther. 14:1079-88.
54. Carter BJ. (2005) Adeno-associated virus vectors in clinical trials. Hum. Gene Ther. 16:541-50.
55. Sinn PL, Sauter SL, McCray PB Jr. (2005) Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther. 12:1089-98.
56. Kohn DB, Sadelain M, Glorioso JC. (2003) Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer. 3:477-88.
57. Hacein-Bey-Abina S, et al. (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118:3132-42.
58. Howe SJ, et al. (2008) Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118:3143-50.
59. Park F. (2007) Lentiviral vectors: are they the future of animal transgenesis? Physiol. Genomics. 31:159-73.
60. Park JW, et al. (2001) Tumor targeting using anti-her2 immunoliposomes. J. Control Release. 74:95-113.
61. Park JW, et al. 1995 Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. U. S. A. 92:1327-31.
62. Sofou S, Sgouros G. (2008) Antibody-targeted liposomes in cancer therapy and imaging. Expert Opin. Drug Deliv. 5:189-204.
63. Torchilin VP. (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu. Rev. Biomed. Eng. 8:343-75.
64. Sato Y, et al. (2008) Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 26:431-42.
65. Seternes T, Sorensen K, Smedsrod B. (2002) Scavenger endothelial cells of vertebrates: a nonperipheral leukocyte system for high-capacity elimination of waste macromolecules. Proc. Natl. Acad. Sci. U. S. A. 99:7594-7.
66. Herweijer H, Wolff JA. (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther. 10:453-8.
67. Hyde SC, et al. (2000) Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 7:1156-65.
68. Joliot A, Prochiantz A. (2004) Transduction pep-tides: from technology to physiology. Nat. Cell Biol. 6:189-96.
69. Gratton JP, et al. (2003) Cell-permeable peptides improve cellular uptake and therapeutic gene de-livery of replication-deficient viruses in cells and in vivo. Nat. Med. 9:357-62.
70. Seymour LW, et al. (2002) Hepatic drug targeting: phase I evaluation of polymer-bound doxoru-bicin. J. Clin. Oncol. 20:1668-76.
71. Li SD, Chen YC, Hackett MJ, Huang L. (2008) Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol. Ther. 16:163-9.
72. Saalik P, et al. (2004) Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug. Chem. 15:1246-53.
73. Richard JP, et al. (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280:15300-6.
74. Wadia JS, Stan RV, Dowdy SF. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10:310-5.
75. Nishimura S, et al. (2008) Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells. J. Biol. Chem. 283:11752-62.
76. Kaplan IM, Wadia JS, Dowdy SF. (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control Release. 102:247-53.
77. Yoshioka Y, et al. (2008) Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency. Life Sci. 83:747-55.
78. Sonawane ND, Szoka FC Jr, Verkman AS. (2003) Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 278:44826-31.
79. Boeckle S, Wagner E, Ogris M. (2005) C- versus N-terminally linked melittin-polyethylenimine conjugates: the site of linkage strongly influences activity of DNA polyplexes. J. Gene Med. 7:1335-47.